CIK 0001746473
- Non-accelerated filer
- Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474272481
- Phone
- +1 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- 4 Grant or award General Counsel & Corp. Sec'y acquired 39,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 57,000 shares (grant or award)
- 4 Open-market sale President and CEO sold 55,000 shares at an average $35.32 ($1,942,336)
- 4 Open-market sale President and CEO sold 60,000 shares at an average $33.12 ($1,987,473)
- 4 Open-market sale General Counsel & Corp. Sec'y sold 20,000 shares at $34.19 ($683,878)
- 4 Open-market sale Chief Medical Officer sold 67,500 shares at $34.48 ($2,327,630)
- 4 Open-market sale Chief Financial Officer sold 30,000 shares at $35.00 ($1,050,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President and CEO sold 20,000 shares at an average $19.07 ($381,413)
- 4 Open-market sale President and CEO sold 30,000 shares at an average $19.20 ($575,892)
- 4 Option exercise Chief Financial Officer acquired 4,000 shares (option exercise)
- 4 Open-market sale General Counsel & Corp. Sec'y sold 2,928 shares at $19.38 ($56,731)
- 4 Open-market sale Chief Financial Officer sold 9,643 shares at $19.10 ($184,204)
- 4 Open-market sale President and CEO sold 34,212 shares at $19.10 ($653,531)
- 4 Open-market sale Chief Medical Officer sold 10,887 shares at $19.10 ($207,968)
- 4 Open-market sale General Counsel & Corp. Sec'y sold 4,719 shares at $19.10 ($90,144)
- 4 Open-market sale Chief Business Officer sold 8,748 shares at $19.10 ($167,108)
- 4 Other disposition 10% owner disposed of 2,000,000 shares (other)
- 4 Open-market sale Chief Medical Officer sold 5,000 shares at $25.05 ($125,241)
Page 7 of 11 · 215 filings